Defunct Company
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
124
NCT02463968
Chikungunya Arthritis in the Americas
Phase: N/A
Role: Collaborator
Start: Aug 27, 2016
Completion: Jun 30, 2017
NCT04597437
Zanamivir Treatment of Vascular Permeability in Dengue (ZAP-DENGUE)
Phase: Phase 2
Start: Mar 15, 2024
Completion: Sep 30, 2026